Healthcare Ventures
Welcome to Rothschild Corp’s Healthcare Ventures. We are at the forefront of transforming healthcare through innovation, advanced research, and sustainable practices. Our investments in healthcare span a diverse range of cutting-edge solutions designed to improve lives and address global health challenges
Live Well Pharmaceuticals
Live Well Pharmaceuticals specializes in the production of high-quality generic pharmaceuticals. Our commitment to affordability and accessibility ensures that essential medicines reach a broad population
Market Insights
The generic pharmaceuticals market is projected to reach USD 740.5 Billion by 2032, growing at a CAGR of 8.1% from 2024 to 2032
Innovation and Impact
We focus on developing cost-effective treatments for widespread health conditions, driving global health improvements
Tumulus Pharmaceuticals offers cutting-edge biotech-based healthcare solutions. We are dedicated to advancing biotechnology to treat complex diseases and improve patient outcomes
Market Insights
The biotech healthcare market is expected to reach USD 3,879.51 Billion by 2031, with a CAGR of 13.9% from 2024 to 2031
Innovation and Impact
Our focus on biotechnological advancements positions us as leaders in innovative healthcare solutions
Market Insights
The Myco-medicine Market was valued at USD 50.3 billion in 2019 and is projected to grow from USD 55.18 billion in 2023 to USD 126.95 billion by 2031, with an anticipated CAGR of 9.7% during the forecast period (2024-2031).
Innovation and Impact
We are at the forefront of the medicinal mushroom industry, driving growth through advanced cultivation techniques, product diversification, and sustainable practices.
Developing products like Ganoderma extracts, this partnership blends traditional remedies with modern science, setting new standards in hepatobiliary care.
Our Sheep Placenta Cellular Therapy division pioneers advanced cell therapy treatments, leveraging the regenerative properties of sheep placenta cells
Market Insights
The market size for sheep placenta cellular therapy is projected to be USD 70.47 million in 2024, growing at a CAGR of 8.27%
Innovation and Impact
We are at the cutting edge of regenerative medicine, offering novel therapies for cellular rejuvenation and healing
We have a wide range on newly launched products which include health supplements, skin care products and raw materials
Market Insights
The Goji Berries market size is USD 341.6 million by 2031 and is expected to expand at a CAGR of 7.2% during the forecast period from 2024 to 2031. This growth is driven by the increasing global demand for Goji Berries, particularly in the medicine and food industries, as well as other applications.
Innovation and Impact
We are leading the way in harnessing the benefits of Goji Berries, offering innovative solutions that cater to the burgeoning demand for natural health products and supplements
